Microbot Medical MBOT Deferred Tax Assets Operation Lease Liabilities
Deferred Tax Assets Operation Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Microbot Medical in its filing.
Tagged under the XBRL concept MBOT:DeferredTaxAssetsOperationLeaseLiabilities.
The official record: Microbot Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Microbot Medical's deferred tax assets operation lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Microbot Medical's deferred tax assets operation lease liabilities?
- Microbot Medical (MBOT) reported deferred tax assets operation lease liabilities of $198K in Q4 2025.
- How has Microbot Medical's deferred tax assets operation lease liabilities changed year-over-year?
- Microbot Medical's deferred tax assets operation lease liabilities increased by 661.5% year-over-year, from $26K to $198K.
- What is the long-term trend for Microbot Medical's deferred tax assets operation lease liabilities?
- Over 4 years (2021 to 2025), Microbot Medical's deferred tax assets operation lease liabilities has grown at a 6.1% compound annual growth rate (CAGR), from $156K to $198K.
- What does deferred tax assets operation lease liabilities mean?
- This metric captures the deferred tax assets specifically attributable to temporary differences arising from operating lease liabilities. It reflects the future tax benefits the company expects to realize as lease-related expenses are recognized for tax purposes differently than for financial reporting. This figure is essential for understanding the tax implications of the company's leasing strategy and its impact on future cash flows.